RESUMO
BACKGROUND: When temporary arterial occlusion of the parent artery is difficult for anatomical reasons, or when inadvertent aneurysmal rupture occurs during surgical dissection, adenosine administration can be used to produce flow arrest and brief, profound systemic hypotension that can facilitate intracranial aneurysm clip ligation. There is a concern, however, that the flow arrest and profound hypotension produced by adenosine, although brief, may cause cerebral ischemia and therefore worsen neurologic outcome compared with other techniques to facilitate aneurysm clip ligation. Therefore, we performed a retrospective, case-control study to determine whether adenosine-induced flow arrest had negative effects on the neurologic outcome of our patients. METHODS: We reviewed the perioperative records of all patients in our intracranial aneurysm surgery outcomes database between August 1, 2006, and June 15, 2012. The primary outcome was the presence or absence of a poor neurologic outcome 48 hours after surgery, with a modified Rankin scale score >2 being defined as a poor neurologic outcome. The neurologic outcome at the time of hospital discharge was a secondary outcome. Secondary outcomes related to cardiac morbidity included atrial or ventricular arrhythmia requiring treatment and elevated cardiac biomarkers consistent with ischemia (i.e., Troponin-I). RESULTS: During the study period, adenosine-induced flow arrest was used in 72 of the 413 patients (17.4%) who underwent intracranial aneurysm clip ligation. The difference in the incidence of poor neurological outcome, with or without the use of adenosine, was no larger than 15.7% at 48 hours after surgery (P =0.524) or -12.7% at discharge (P = 0.741). In addition, the difference in the incidence of cardiac morbidity was no larger than -16.0% for persistent arrhythmia (P = 0.155) or -9.4% for biomarkers of myocardial ischemia (P = 0.898) in the initial 48 hours after surgery. CONCLUSION: When used to facilitate intracranial aneurysm clip ligation, adenosine-induced flow arrest was associated with no more than a 15.7% increase or a 12.7% decrease in the incidence of a poor neurologic outcome at either 48 hours or at the time of hospital discharge. In addition, adenosine use was not associated with cardiac morbidity in the perioperative period (i.e., persistent arrhythmia or biomarkers of cardiac ischemia).
Assuntos
Adenosina/efeitos adversos , Aneurisma Intracraniano/cirurgia , Doenças do Sistema Nervoso/etiologia , Procedimentos Neurocirúrgicos/efeitos adversos , Instrumentos Cirúrgicos/efeitos adversos , Adulto , Idoso , Arritmias Cardíacas/etiologia , Estudos de Casos e Controles , Circulação Cerebrovascular/efeitos dos fármacos , Feminino , Humanos , Ligadura/efeitos adversos , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/etiologia , Doenças do Sistema Nervoso/diagnóstico , Procedimentos Neurocirúrgicos/métodos , Perfusão , Assistência Perioperatória , Estudos Retrospectivos , Resultado do TratamentoRESUMO
BACKGROUND: The use of flexible laryngeal mask airway (FLMA) in elective ear, nose and throat (ENT) surgery offers significant advantages, but is frequently considered inferior to tracheal intubation (TI) for ventilation and airway protection. We investigated the safety and success rate of intraoperative FLMA use with positive pressure ventilation (PPV), and the factors responsible for FLMA failure. METHODS: A 15-year single center retrospective study. FLMA failure was defined as the need for FLMA removal and TI, either during induction (primary failure), or after turning the patient over to the surgeon (secondary failure). Strict failure criteria included the inability to achieve and/or maintain all 3 essential FLMA functions, such as ventilation (tidal volume ≥6 mL/kg), airway protection from above the cuff (airway sealing pressure [ASP] >12 cm H2O), and separation of the respiratory and gastrointestinal tracts (absent gastric insufflation during PPV). RESULTS: In 685 patients, FLMA was successfully inserted in 94%. Secondary failure rate was 1.5%, with half of failures observed intraoperatively. The inability to seat FLMA during induction or FLMA dislodgment were the most common reasons for failures. The number of FLMA insertion attempts and low ASP were associated with FLMA primary failure and the need for TI. There were no complications. CONCLUSIONS: The results suggest an acceptably low failure rate of use of FLMA with PPV in selected ENT surgical procedures. True intraoperative FLMA failure is uncommon. We advocate observing strict criteria for adequacy of FLMA placement, and close monitoring of FLMA function intraoperatively at all times.
Assuntos
Cuidados Intraoperatórios/métodos , Máscaras Laríngeas , Procedimentos Cirúrgicos Otorrinolaringológicos , Respiração com Pressão Positiva , Adulto , Procedimentos Cirúrgicos Eletivos , Humanos , Máscaras Laríngeas/efeitos adversos , Estudos Retrospectivos , Fatores de Tempo , Resultado do TratamentoRESUMO
Although office-based anesthesia for facial cosmetic surgery remains remarkably safe, no anesthesia or sedation performed outside the operating room should be considered minor. Proper organization, preparation, and patient selection, close collaboration with the surgeon, and expert and effective anesthesia care will increase patient safety and improve perioperative outcomes and patient satisfaction. This article presents a comprehensive overview of anesthesia in terms of facial plastic surgery procedures, beginning with a broad review of essentials and pitfalls of anesthesia, followed by details of specific anesthetic agents, their administration, mechanism of action, and complications.
Assuntos
Anestesia/efeitos adversos , Técnicas Cosméticas , Face/cirurgia , Complicações Intraoperatórias/prevenção & controle , Assistência Perioperatória/métodos , Procedimentos de Cirurgia Plástica/métodos , Complicações Pós-Operatórias/prevenção & controle , Anestesia/métodos , Anestesia/normas , Período de Recuperação da Anestesia , Lista de Checagem , Humanos , Complicações Intraoperatórias/induzido quimicamente , Monitorização Intraoperatória , Segurança do Paciente , Seleção de Pacientes , Complicações Pós-Operatórias/induzido quimicamente , Guias de Prática Clínica como AssuntoRESUMO
BACKGROUND: Mannitol is often used during intracranial surgery to improve surgical exposure. Furosemide is often added to mannitol to augment this effect. The concern exists, however, that the augmented diuresis caused by the addition of furosemide to mannitol may cause hypovolemia and hypoperfusion, hypokalemia, and hyponatremia. We examined the intraoperative safety of low-dose furosemide (0.3 mg/kg) combined with mannitol (1 g/kg). METHODS: We observed 23 patients in a double-blind, block randomized, placebo-controlled study to examine the effects of furosemide (0.3 mg/kg) when combined with mannitol (1 g/kg) on surgical brain relaxation for tumor surgery. Mannitol and the study drug (furosemide or placebo) were administered, and arterial blood gases with electrolytes (sodium, potassium, and lactic acid) and urine output volume were recorded every 30 minutes for 3 hours. Plasma sodium, potassium, and lactic acid concentrations, and interval urine outputs, were compared across time and between furosemide-placebo assignment groupings, with a P<0.01 considered significant. RESULTS: Although mannitol produced a large volume of diuresis (1533±335 mL), the addition of a low dose of furosemide substantially increased both the rate of production of urine for the first 90 minutes after administration and the total volume of urine produced (2561±611 mL, P<0.001, compared with placebo group). The addition of furosemide did not produce a serum potassium level below 3.8±0.7 mEq/L, a serum sodium level below 128.3±3.4 mEq/L, or a serum lactic acid level above 2.4±0.9 mmol/L. There were no differences in the plasma potassium concentration, sodium concentration, or lactic acid concentration between the drug groups at any time point. CONCLUSIONS: Despite an increase in urine output by as much as 67%, adding low-dose furosemide to mannitol does not seem to produce significant electrolyte derangements or hypovolemia compared with the administration of mannitol alone.
Assuntos
Volume Sanguíneo/efeitos dos fármacos , Diuréticos/farmacologia , Eletrólitos/sangue , Furosemida/farmacologia , Manitol/uso terapêutico , Adulto , Idoso , Pressão Arterial/efeitos dos fármacos , Neoplasias Encefálicas/cirurgia , Soluções Cristaloides , Diuréticos/efeitos adversos , Método Duplo-Cego , Feminino , Furosemida/efeitos adversos , Hemodinâmica/fisiologia , Humanos , Cuidados Intraoperatórios , Soluções Isotônicas/uso terapêutico , Ácido Láctico/sangue , Masculino , Manitol/efeitos adversos , Pessoa de Meia-Idade , Procedimentos Neurocirúrgicos/métodos , Segurança do Paciente , Substitutos do Plasma/uso terapêutico , Urodinâmica/efeitos dos fármacosRESUMO
The waterpipe is an ancient Middle Eastern tobacco delivery system, which is also known as hookah, shisha, or narghile, and it is gaining widespread use. Waterpipes are often perceived as less dangerous than cigarettes. The amount of smoke inhaled in a waterpipe session may equal that produced by more than 100 cigarettes with high nicotine, carbon monoxide, and carcinogen intake. A case of significantly elevated intraoperative carboxyhemoglobin level and decreased oxyhemoglobin saturation in a patient with recent waterpipe use is presented.